Use of proton pump inhibitor as a diagnostic test in NCCP

J Gastroenterol Hepatol. 2005 Dec:20 Suppl:S14-7. doi: 10.1111/j.1440-1746.2005.04166.x.

Abstract

Non-cardiac chest pain (NCCP) is the most common extra-esophageal manifestation of gastroesophageal reflux disease. The proton pump inhibitor empirical trial (PPI test) is a simple non-invasive, accurate and cost-saving test for evaluating patients with GERD-related NCCP. The review will discuss the use of the PPI test as a diagnostic test for NCCP.

Publication types

  • Review

MeSH terms

  • Anti-Ulcer Agents*
  • Chest Pain / diagnosis*
  • Chest Pain / etiology
  • Diagnosis, Differential
  • Gastroesophageal Reflux / complications
  • Gastroesophageal Reflux / diagnosis*
  • Humans
  • Proton Pump Inhibitors*

Substances

  • Anti-Ulcer Agents
  • Proton Pump Inhibitors